Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
101 | 4401 | 43.1 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
639 | 3 | ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE | 12578 |
818 | 2 | ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE | 11927 |
101 | 1 | ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//ATOMOXETINE | 4401 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADHD | authKW | 1557135 | 26% | 20% | 1144 |
2 | ATTENTION DEFICIT HYPERACTIVITY DISORDER | authKW | 1546581 | 22% | 23% | 954 |
3 | ATOMOXETINE | authKW | 717119 | 5% | 47% | 220 |
4 | METHYLPHENIDATE | authKW | 655166 | 9% | 23% | 410 |
5 | JOURNAL OF ATTENTION DISORDERS | journal | 574953 | 5% | 35% | 238 |
6 | ADULT ADHD | authKW | 372791 | 2% | 49% | 109 |
7 | PEDIAT PSYCHOPHARMACOL UNIT | address | 317536 | 2% | 43% | 107 |
8 | STIMULANTS | authKW | 317455 | 5% | 21% | 221 |
9 | STIMULANT MEDICATION | authKW | 212295 | 1% | 47% | 65 |
10 | LISDEXAMFETAMINE DIMESYLATE | authKW | 195353 | 1% | 72% | 39 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 107681 | 56% | 1% | 2462 |
2 | Psychology, Developmental | 46063 | 18% | 1% | 799 |
3 | Pediatrics | 20426 | 24% | 0% | 1053 |
4 | Psychology, Clinical | 6603 | 9% | 0% | 399 |
5 | Pharmacology & Pharmacy | 3672 | 19% | 0% | 829 |
6 | Substance Abuse | 2816 | 4% | 0% | 173 |
7 | Clinical Neurology | 2653 | 12% | 0% | 529 |
8 | Medicine, General & Internal | 489 | 7% | 0% | 289 |
9 | Health Policy & Services | 469 | 2% | 0% | 86 |
10 | Psychology | 458 | 3% | 0% | 119 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEDIAT PSYCHOPHARMACOL UNIT | 317536 | 2% | 43% | 107 |
2 | CLIN PROGRAM PEDIAT PSYCHOPHARMACOL | 121010 | 1% | 36% | 48 |
3 | ADULT ADHD PROGRAM | 86700 | 0% | 83% | 15 |
4 | CHILD ADOLESCENT PSYCHIAT | 70885 | 7% | 3% | 306 |
5 | DUKE ADHD PROGRAM | 51074 | 0% | 82% | 9 |
6 | ADHD OUTPATIENT PROGRAM | 50096 | 0% | 43% | 17 |
7 | PSYCHIAT | 42459 | 25% | 1% | 1113 |
8 | CLIN PROGRAM PEDIAT PSYCHOPHARMACOL ADULT | 41852 | 0% | 46% | 13 |
9 | ADVANCEMENT CHILDRENS MENTAL HLTH | 40408 | 0% | 45% | 13 |
10 | ADHD PROGRAM | 38139 | 0% | 50% | 11 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ATTENTION DISORDERS | 574953 | 5% | 35% | 238 |
2 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 193176 | 4% | 15% | 188 |
3 | JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 114798 | 6% | 6% | 285 |
4 | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 29346 | 2% | 5% | 80 |
5 | CNS DRUGS | 15674 | 1% | 4% | 63 |
6 | CNS SPECTRUMS | 15284 | 1% | 5% | 49 |
7 | PSYCHOPHARMACOLOGY BULLETIN | 11635 | 1% | 3% | 55 |
8 | JOURNAL OF CLINICAL PSYCHIATRY | 11474 | 2% | 2% | 109 |
9 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | 7607 | 1% | 3% | 41 |
10 | BMC PSYCHIATRY | 5788 | 1% | 2% | 46 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADHD | 1557135 | 26% | 20% | 1144 | Search ADHD | Search ADHD |
2 | ATTENTION DEFICIT HYPERACTIVITY DISORDER | 1546581 | 22% | 23% | 954 | Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER | Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER |
3 | ATOMOXETINE | 717119 | 5% | 47% | 220 | Search ATOMOXETINE | Search ATOMOXETINE |
4 | METHYLPHENIDATE | 655166 | 9% | 23% | 410 | Search METHYLPHENIDATE | Search METHYLPHENIDATE |
5 | ADULT ADHD | 372791 | 2% | 49% | 109 | Search ADULT+ADHD | Search ADULT+ADHD |
6 | STIMULANTS | 317455 | 5% | 21% | 221 | Search STIMULANTS | Search STIMULANTS |
7 | STIMULANT MEDICATION | 212295 | 1% | 47% | 65 | Search STIMULANT+MEDICATION | Search STIMULANT+MEDICATION |
8 | LISDEXAMFETAMINE DIMESYLATE | 195353 | 1% | 72% | 39 | Search LISDEXAMFETAMINE+DIMESYLATE | Search LISDEXAMFETAMINE+DIMESYLATE |
9 | NONSTIMULANT | 156054 | 1% | 75% | 30 | Search NONSTIMULANT | Search NONSTIMULANT |
10 | ATTENTION DEFICIT HYPERACTIVITY DISORDER ADHD | 153908 | 3% | 18% | 121 | Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER+ADHD | Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER+ADHD |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WILENS, TE , MORRISON, NR , PRINCE, J , (2011) AN UPDATE ON THE PHARMACOTHERAPY OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN ADULTS.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 11. ISSUE 10. P. 1443-1465 | 134 | 92% | 42 |
2 | NI, HC , LIN, YJ , GAU, SSF , HUANG, HC , YANG, LK , (2017) AN OPEN-LABEL, RANDOMIZED TRIAL OF METHYLPHENIDATE AND ATOMOXETINE TREATMENT IN ADULTS WITH ADHD.JOURNAL OF ATTENTION DISORDERS. VOL. 21. ISSUE 1. P. 27 -39 | 43 | 81% | 5 |
3 | KOOIJ, SJJ , BEJEROT, S , BLACKWELL, A , CACI, H , CASAS-BRUGUE, M , CARPENTIER, PJ , EDVINSSON, D , FAYYAD, J , FOEKEN, K , FITZGERALD, M , ET AL (2010) EUROPEAN CONSENSUS STATEMENT ON DIAGNOSIS AND TREATMENT OF ADULT ADHD: THE EUROPEAN NETWORK ADULT ADHD.BMC PSYCHIATRY. VOL. 10. ISSUE . P. - | 146 | 59% | 153 |
4 | ROSTAIN, A , JENSEN, PS , CONNOR, DF , MIESLE, LM , FARAONE, SV , (2015) TOWARD QUALITY CARE IN ADHD: DEFINING THE GOALS OF TREATMENT.JOURNAL OF ATTENTION DISORDERS. VOL. 19. ISSUE 2. P. 99 -117 | 124 | 78% | 3 |
5 | HUANG, YS , TSAI, MH , (2011) LONG-TERM OUTCOMES WITH MEDICATIONS FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER CURRENT STATUS OF KNOWLEDGE.CNS DRUGS. VOL. 25. ISSUE 7. P. 539 -554 | 102 | 93% | 15 |
6 | PLISZKA, S , BERNET, W , BUKSTEIN, O , WALTER, HJ , ARNOLD, V , BEITCHMAN, J , BENSON, RS , CHRISMAN, A , FARCHIONE, T , HAMILTON, J , ET AL (2007) PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. VOL. 46. ISSUE 7. P. 894-921 | 84 | 69% | 495 |
7 | KATZMAN, M , STERNAT, T , (2014) A REVIEW OF OROS METHYLPHENIDATE (CONCERTA (R)) IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.CNS DRUGS. VOL. 28. ISSUE 11. P. 1005 -1033 | 96 | 81% | 10 |
8 | MAY, DE , KRATOCHVIL, CJ , (2010) ATTENTION-DEFICIT HYPERACTIVITY DISORDER RECENT ADVANCES IN PAEDIATRIC PHARMACOTHERAPY.DRUGS. VOL. 70. ISSUE 1. P. 15 -40 | 98 | 80% | 38 |
9 | CHILDRESS, AC , (2016) A CRITICAL APPRAISAL OF ATOMOXETINE IN THE MANAGEMENT OF ADHD.THERAPEUTICS AND CLINICAL RISK MANAGEMENT. VOL. 12. ISSUE . P. - | 71 | 87% | 3 |
10 | SAVILL, NC , BUITELAAR, JK , ANAND, E , DAY, KA , TREUER, T , UPADHYAYA, HP , COGHILL, D , (2015) THE EFFICACY OF ATOMOXETINE FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A COMPREHENSIVE REVIEW OF OVER A DECADE OF CLINICAL RESEARCH.CNS DRUGS. VOL. 29. ISSUE 2. P. 131 -151 | 96 | 72% | 4 |
Classes with closest relation at Level 1 |